Prevenção e Reabilitação Cardiovascular - page 122

Vanda Craveiro, Gabriela Albuquerque, Andreia Oliveira
12012
Bibliografia
1. Balady GJ, Ades PA, Comoss P
et al. Core components of cardiac rehabilitation/secondary
prevention programs: A statement for healthcare professionals from the American Heart
Association and the American Association of Cardiovascular and Pulmonary Rehabilitation
Writing Group. Circulation. 2000
;
102: 1069‑1073.
2. Balady GJ, Williams MA, Ades PA
et al
.
Core components of cardiac rehabilitation/secon-
dary prevention programs: 2007 update: a scientific statement from the American Heart
Association Exercise, Cardiac Rehabilitation, and Prevention Committee, the Council on
Clinical Cardiology; the Councils on Cardiovascular Nursing, Epidemiology and Prevention,
and Nutrition, Physical Activity, and Metabolism; and the American Association of Cardio-
vascular and Pulmonary Rehabilitation. Circulation. 2007
;
115: 2675‑2682.
3. Krauss RM, Eckel RH, Howard B et al
.
AHA Dietary Guidelines: revision 2000: A statement
for healthcare professionals from the Nutrition Committee of the American Heart Associa-
tion. Circulation. 2000
;
102: 2284‑2299.
4. Krauss RM, Deckelbaum RJ, Ernst N
et al
.
Dietary guidelines for healthy American adults. A
statement for health professionals from the Nutrition Committee, American Heart Associa-
tion. Circulation. 1996
;
94: 1795‑1800.
5. Lichtenstein AH, Appel LJ, Brands M et al
.
Diet and lifestyle recommendations revision 2006:
a scientific statement from the American Heart Association Nutrition Committee. Circula-
tion. 2006
;
114: 82‑96.
6. National Cholesterol Education Program. Third Report of the National Cholesterol Education
Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cho-
lesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;
106: 3143‑3421.
7. Smith SC, Jr., Allen J, Blair SN
et al
.
AHA/ACC guidelines for secondary prevention for
patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by
the National Heart, Lung, and Blood Institute. Circulation
.
2006
;
113: 2363‑2372.
8. Smith SC, Jr., Benjamin EJ, Bonow RO
et al
.
AHA/ACCF Secondary Prevention and Risk
Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease:
2011 update: a guideline from the American Heart Association and American College of
Cardiology Foundation. Circulation. 2011
;
124: 2458‑2473.
9. Stone NJ, Robinson JG, Lichtenstein AH
et al
.
2013 ACC/AHA guideline on the treatment
of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the
American College of Cardiology/American Heart Association Task Force on Practice Guide-
lines. Circulation. 2014;
129: S1‑45.
10. Eckel RH, Jakicic JM, Ard JD et al
.
2013 AHA/ACC guideline on lifestyle management to
reduce cardiovascular risk: a report of the American College of Cardiology/American Heart
Association Task Force on Practice Guidelines. Circulation. 2014
;
129: S76‑99.
11. Mozaffarian D, Wu JH. (n‑3) fatty acids and cardiovascular health: are effects of EPA and
DHA shared or complementary? J Nutr.
2012
;
142: 614S‑625S.
12. Gebauer SK, Psota TL, Harris WS
et al. n‑3 fatty acid dietary recommendations and food
sources to achieve essentiality and cardiovascular benefits. Am J Clin Nutr.
2006
;
83:
1526S‑1535S.
1...,112,113,114,115,116,117,118,119,120,121 123,124,125,126,127,128,129,130,131,132,...404
Powered by FlippingBook